Oxford Immunotec Global PLC (NASDAQ:OXFD)

13.87
Delayed Data
As of Jun 22
 -0.21 / -1.49%
Today’s Change
10.00
Today|||52-Week Range
19.51
-0.72%
Year-to-Date
No recent news for Oxford Immunotec Global PLC.

Today’s Trading

Previous close14.08
Today’s open14.11
Day’s range13.68 - 14.26
Volume434,869
Average volume (3 months)161,773
Market cap$344.2M
Data as of 4:00pm ET, 06/22/2018

Growth & Valuation

Earnings growth (last year)-38.00%
Earnings growth (this year)+28.12%
Earnings growth (next 5 years)--
Revenue growth (last year)+19.75%
P/E ratioNM
Price/Sales3.22
Price/Book3.89

Competitors

 Today’s
change
Today’s
% change
CLDXCelldex Therapeutics...-0.04-6.38%
VCYTVeracyte Inc-0.11-1.14%
VIVOMeridian Bioscience ...0.000.00%
CALACalithera Bioscience...0.000.00%
Data as of 4:00pm ET, 06/22/2018

Financials

Next reporting dateAugust 7, 2018
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$103.1M
Annual profit (last year)-$32.9M
Net profit margin-31.90%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chief Executive Officer &
Executive Director
Peter James Wrighton-Smith
Chief Operating Officer
Stefan C. Linn
Corporate headquarters
Abingdon, Oxfordshire

Forecasts